Skip to main content

Together we are beating cancer

Donate now

Cervical cancer

Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
Showing 12 out of 116 results
Vaccine vial and needle

Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023. Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023.

by In collaboration with PA Media Group | News | 21 June 2023

21 June 2023

A magnified image of squamous cell carcinoma, the most common type of cervical cancer

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

by Tim Gunn | News | 16 May 2023

16 May 2023

Two of our Cancer Awareness Nurses at a stop of our Cancer Awareness Roadshow

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

by Sophie Marshall | In depth | 2 March 2023

2 March 2023

A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022

This entry is part 1 of 3 in the series CRUK Global

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

by Lilly Matson | Analysis | 27 April 2022

27 April 2022

A 3d rendered image of HPV cells

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch. Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

by Alice Davies | Analysis | 7 January 2022

7 January 2022

That Cancer Conversation in a white speech bubble with a dark blue background

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer. Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer.

by Cancer Research UK | Podcast | 9 December 2021

9 December 2021

This entry is part 4 of 21 in the series That Cancer Conversation
A photograph of a lady holding a vaccine and needle.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

by Lilly Matson | In depth | 17 November 2021

17 November 2021

It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide. It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.

by Rachel Orritt | Analysis | 25 October 2021

25 October 2021